Literature DB >> 21826451

Homing of cancer cells to the bone.

Anjali Mishra1, Yusuke Shiozawa, Kenneth J Pienta, Russell S Taichman.   

Abstract

A variety of tumor cells preferentially home to the bone. The homing of cancer cells to the bone represents a multi-step process that involves malignant progression of the tumor, invasion of the tumor through the extracellular matrix and the blood vessels and settling of the tumor cells in the bone. Gaining a greater understanding as to the mechanisms used by cancer cells in these processes will facilitate the design of drugs which could specifically target the homing process. In this review we will discuss the properties of tumor cells and the bone microenvironment which promote homing of a cancer cell to the bone. We will highlight the different steps and the molecular pathways involved when a cancer cell metastasize to the bone. Since bone is the major home for hematopoietic stem cells (HSCs), we will also highlight the similarities between the homing of cancer and HSC to the bone. Finally we will conclude with therapeutic and early detection strategies which can prevent homing of a cancer cell to the bone.

Entities:  

Year:  2011        PMID: 21826451      PMCID: PMC3234327          DOI: 10.1007/s12307-011-0083-6

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  194 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 2.  The role of the organ microenvironment in the biology and therapy of cancer metastasis.

Authors:  Isaiah J Fidler; Sun-Jin Kim; Robert R Langley
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

3.  Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.

Authors:  K F Bradstock; V Makrynikola; A Bianchi; W Shen; J Hewson; D J Gottlieb
Journal:  Leukemia       Date:  2000-05       Impact factor: 11.528

4.  Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

Authors:  Meike Burger; Tanja Hartmann; Myriam Krome; Justyna Rawluk; Hirokazu Tamamura; Nobutaka Fujii; Thomas J Kipps; Jan A Burger
Journal:  Blood       Date:  2005-05-19       Impact factor: 22.113

5.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Authors:  Manit Arya; Hitendra R H Patel; Claire McGurk; Roger Tatoud; Helmut Klocker; John Masters; Magali Williamson
Journal:  J Exp Ther Oncol       Date:  2004-12

6.  The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.

Authors:  Jitesh Pratap; Amjad Javed; Lucia R Languino; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Ca(2+)-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells.

Authors:  J L Sanders; N Chattopadhyay; O Kifor; T Yamaguchi; E M Brown
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

8.  Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

Authors:  Bruno Nervi; Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Matthew S Holt; Julie K Ritchey; Julie L Prior; David Piwnica-Worms; Gary Bridger; Timothy J Ley; John F DiPersio
Journal:  Blood       Date:  2008-12-02       Impact factor: 22.113

Review 9.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

10.  Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.

Authors:  Tzu-Hsiu Lai; Yi-Chin Fong; Wen-Mei Fu; Rong-Sen Yang; Chih-Hsin Tang
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

View more
  28 in total

1.  MRI for the detection of prostate cancer origin vertebral metastases in the preosteoblastic phase.

Authors:  Swaroop Revannasiddaiah; Madhup Rastogi; Pragyat Thakur; Manoj Kumar Gupta; Ashwani Sood; Chittranjan Sharma
Journal:  BMJ Case Rep       Date:  2012-07-09

Review 2.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

Review 3.  Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.

Authors:  Emma E van der Toom; Haley D Axelrod; Jean J de la Rosette; Theo M de Reijke; Kenneth J Pienta; Kenneth C Valkenburg
Journal:  Nat Rev Urol       Date:  2019-01       Impact factor: 14.432

4.  Optical imaging of progenitor cell homing to patient-derived tumors.

Authors:  Isabel G Newton; Warren C Plaisted; Steven Messina-Graham; Annelie E Abrahamsson Schairer; Alice Y Shih; Evan Y Snyder; Catriona H M Jamieson; Robert F Mattrey
Journal:  Contrast Media Mol Imaging       Date:  2012 Nov-Dec       Impact factor: 3.161

Review 5.  Disseminated tumor cells and dormancy in prostate cancer metastasis.

Authors:  Emma E van der Toom; James E Verdone; Kenneth J Pienta
Journal:  Curr Opin Biotechnol       Date:  2016-02-20       Impact factor: 9.740

Review 6.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

7.  Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.

Authors:  Didier Meseure; Kinan Drak Alsibai; Andre Nicolas
Journal:  Cancer Microenviron       Date:  2014-12-19

8.  PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.

Authors:  Arti Verma; Sandeep Artham; Abdulrahman Alwhaibi; Mir S Adil; Brian S Cummings; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-03-30       Impact factor: 5.858

Review 9.  Biomechanical forces in the skeleton and their relevance to bone metastasis: biology and engineering considerations.

Authors:  Maureen E Lynch; Claudia Fischbach
Journal:  Adv Drug Deliv Rev       Date:  2014-08-29       Impact factor: 15.470

Review 10.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.